financetom
SRTS
financetom
/
Healthcare
/
SRTS
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Sensus Healthcare, Inc.SRTS
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
74.06M
Revenue (ttm)
41.81M
Net Income (ttm)
6.65M
Shares Out
16.50M
EPS (ttm)
0.41
PE Ratio
10.99
Forward PE
16.59
Dividend
n/a
Ex-Dividend Date
n/a
Volume
29,221
Open
4.600
Previous Close
4.580
Day's Range
4.470 - 4.570
52-Week Range
3.090 - 9.330
Beta
1.12
Analysts
Strong Buy
Price Target
13.00 (+189.53%)
Earnings Date
May 8, 2025
Description >

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide.

The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices.

It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.

The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and TransDermal Infusion system.

In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body, as well as distributes laser devices.

Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Latest News >
Coronavirus News highlights: Delta and Omicron variants spreading like 'tsunami', says TN health minister
Coronavirus News highlights: Delta and Omicron variants spreading like 'tsunami', says TN health minister
Jan 5, 2022
Coronavirus Omicron India News LIVE Updates: The Indian Medical Association (IMA) requested the Centre and states to ensure that COVID duty of resident doctors do not exceed eight hours a day and after a week there should be a quarantine 10 to 14 day quarantine period in accommodation prescribed by the hospital. In the event of a Covid duty doctor falling ill, they should be hospitalised at the earliest. In a statement, the doctors' body said in case of untimely death, the status of COVID martyr and compensation as well as case-wise assistance should be arranged. There should also be a provision for taking care of the mental health of doctors, the IMA said. "Around 2,000 doctors died during the second wave of Covid. The mortality rate in the country was around 1.5 percent among the general population and around 2 to 3 percent among healthcare workers. According to this estimate, Covid occurred in about 1,00,000 doctors," the IMA said.
Australia agrees to delay Novak Djokovic's deportation; full hearing scheduled for January 10
Australia agrees to delay Novak Djokovic's deportation; full hearing scheduled for January 10
Jan 6, 2022
World number one tennis player Novak Djokovic remained in Australia after his lawyers launched an appeal seeking to overturn the federal government decision. A court agreed not to deport him before a full hearing scheduled for Monday, leaving the Serbian champion holed up in a quarantine hotel in Melbourne for at least the next 72 hours.
Funding Rundown: Reliance takes 26% stake in Dunzo for $200 mn, Bombay Shaving Company bags Rs 160 cr & Chalo eyeing $200 mn fundraise, says report
Funding Rundown: Reliance takes 26% stake in Dunzo for $200 mn, Bombay Shaving Company bags Rs 160 cr & Chalo eyeing $200 mn fundraise, says report
Jan 6, 2022
Here's a lowdown of the top deals from the startup space.
India vs South Africa 2nd Test: SA win by 7 wickets, level series 1-1
India vs South Africa 2nd Test: SA win by 7 wickets, level series 1-1
Jan 6, 2022
South Africa defeated India by seven wickets in the second Test to level the three-match series 1-1 on Thursday. India's bowlers could not extract enough from the surface with Mohammad Shami getting the only wicket to fall on the day. The third and final Test begins in Cape Town from January 11.
Copyright 2023-2025 - www.financetom.com All Rights Reserved